|
1
|
Perou CM, Sørlie T, Eisen MB, van de Rijn
M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA,
et al: Molecular portraits of human breast tumours. Nature.
406:747–752. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gruvberger S, Ringnér M, Chen Y, Panavally
S, Saal LH, Borg A, Fernö M, Peterson C and Meltzer PS: Estrogen
receptor status in breast cancer is associated with remarkably
distinct gene expression patterns. Cancer Res. 61:5979–5984.
2001.PubMed/NCBI
|
|
3
|
Zhang Y, Martens JW, Yu JX, Jiang J,
Sieuwerts AM, Smid M, Klijn JG, Wang Y and Foekens JA: Copy number
alterations that predict metastatic capability of human breast
cancer. Cancer Res. 69:3795–3801. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Grann VR, Troxel AB, Zojwalla NJ, Jacobson
JS, Hershman D and Neugut AI: Hormone receptor status and survival
in a population-based cohort of patients with breast carcinoma.
Cancer. 103:2241–2251. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Early Breast Cancer Trialists'
Collaborative Group (EBCTCG), ; Davies C, Godwin J, Gray R, Clarke
M, Cutter D, Darby S, McGale P, Pan HC, Taylor C, et al: Relevance
of breast cancer hormone receptors and other factors to the
efficacy of adjuvant tamoxifen: Patient-level meta-analysis of
randomised trials. Lancet. 378:771–784. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thakkar JP and Mehta DG: A review of an
unfavorable subset of breast cancer: Estrogen receptor positive
progesterone receptor negative. Oncologist. 16:276–285. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Arpino G, Weiss H, Lee AV, Schiff R, De
Placido S, Osborne CK and Elledge RM: Estrogen receptor-positive,
progesterone receptor-negative breast cancer: Association with
growth factor receptor expression and tamoxifen resistance. J Natl
Cancer Inst. 97:1254–1261. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Viale G, Regan MM, Maiorano E,
Mastropasqua MG, Dell'Orto P, Rasmussen BB, Raffoul J, Neven P,
Orosz Z, Braye S, et al: Prognostic and predictive value of
centrally reviewed expression of estrogen and progesterone
receptors in a randomized trial comparing letrozole and tamoxifen
adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.
J Clin Oncol. 25:3846–3852. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cancer Genome Atlas Network, .
Comprehensive molecular portraits of human breast tumours. Nature.
490:61–70. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Haverty PM, Fridlyand J, Li L, Getz G,
Beroukhim R, Lohr S, Wu TD, Cavet G, Zhang Z and Chant J:
High-resolution genomic and expression analyses of copy number
alterations in breast tumors. Genes Chromosomes Cancer. 47:530–542.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tian K, Wang Y and Xu H: WTH3 is a direct
target of the p53 protein. Br J Cancer. 96:1579–1586. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tian K, Wang Y, Huang Y, Sun B, Li Y and
Xu H: Methylation of WTH3, a possible drug resistant gene, inhibits
p53 regulated expression. BMC Cancer. 8:3272008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gan L, Zuo G, Wang T, Min J, Wang Y, Wang
Y and Lv G: Expression of WTH3 in breast cancer tissue and the
effects on the biological behavior of breast cancer cells. Exp Ther
Med. 10:154–158. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Y, Klijn JG, Zhang Y, Sieuwerts AM,
Look MP, Yang F, Talantov D, Timmermans M, Meijer-van Gelder ME, Yu
J, et al: Gene-expression profiles to predict distant metastasis of
lymph-node-negative primary breast cancer. Lancet. 365:671–679.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rutqvist LE and Johansson H; Stockholm
Breast Cancer Study Group, : Long-term follow-up of the randomized
Stockholm trial on adjuvant tamoxifen among postmenopausal patients
with early stage breast cancer. Acta Oncol. 46:133–145. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rutqvist LE and Johansson H: Long-term
follow-up of the Stockholm randomized trials of postoperative
radiation therapy versus adjuvant chemotherapy among ‘high risk’
pre- and postmenopausal breast cancer patients. Acta Oncol.
45:517–527. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jerevall PL, Jansson A, Fornander T, Skoog
L, Nordenskjöld B and Stål O: Predictive relevance of HOXB13
protein expression for tamoxifen benefit in breast cancer. Breast
Cancer Res. 12:R532010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wrange O, Nordenskjöld B and Gustafsson
JA: Cytosol estradiol receptor in human mammary carcinoma: An assay
based on isoelectric focusing in polyacrylamide gel. Anal Biochem.
85:461–475. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shan J, Mason JM, Yuan L, Barcia M, Porti
D, Calabro A, Budman D, Vinciguerra V and Xu H: Rab6c, a new member
of the rab gene family, is involved in drug resistance in MCF7/AdrR
cells. Gene. 257:67–75. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shan J, Yuan L, Budman DR and Xu HP: WTH3,
a new member of the Rab6 gene family, and multidrug resistance.
Biochim Biophys Acta. 1589:112–123. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Uhlén M, Björling E, Agaton C, Szigyarto
CA, Amini B, Andersen E, Andersson AC, Angelidou P, Asplund A,
Asplund C, et al: A human protein atlas for normal and cancer
tissues based on antibody proteomics. Mol Cell Proteomics.
4:1920–1932. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bhat S, Kabekkodu SP, Jayaprakash C,
Radhakrishnan R, Ray S and Satyamoorthy K: Gene promoter-associated
CpG island hypermethylation in squamous cell carcinoma of the
tongue. Virchows Arch. 470:445–454. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bhat S, Kabekkodu SP, Varghese VK,
Chakrabarty S, Mallya SP, Rotti H, Pandey D, Kushtagi P and
Satyamoorthy K: Aberrant gene-specific DNA methylation signature
analysis in cervical cancer. Tumour Biol. 39:10104283176945732017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Young J, Menetrey J and Goud B: RAB6C is a
retrogene that encodes a centrosomal protein involved in cell cycle
progression. J Mol Biol. 397:69–88. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Williams TK, Yeo CJ and Brody J: Does this
band make sense? Limits to expression based cancer studies. Cancer
Lett. 271:81–84. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sebat J, Lakshmi B, Troge J, Alexander J,
Young J, Lundin P, Månér S, Massa H, Walker M, Chi M, et al:
Large-scale copy number polymorphism in the human genome. Science.
305:525–528. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Altschul SF, Madden TL, Schäffer AA, Zhang
J, Zhang Z, Miller W and Lipman DJ: Gapped BLAST and PSI-BLAST: A
new generation of protein database search programs. Nucleic Acids
Res. 25:3389–3402. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yates A, Akanni W, Amode MR, Barrell D,
Billis K, Carvalho-Silva D, Cummins C, Clapham P, Fitzgerald S, Gil
L, et al: Ensembl 2016. Nucleic Acids Res. 44:D710–D716. 2016.
View Article : Google Scholar : PubMed/NCBI
|
